The changes in lipid profiles, hormones and lipoproteins indicate a metabolically healthy obesity (MHO) phenotype [16], which is most likely caused by strong hepatic upregulation of the hepatokine fibroblast growth factor 21 (FGF21). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.